The ED Pill That Dialysis Does Not Wash Out

[hinar]

## Dialysis changes the ED conversation

Erectile dysfunction is common in men with chronic kidney disease and end-stage renal disease.

The causes are usually mixed: vascular disease, diabetes, uremia, low testosterone, anemia, neuropathy, depression, medication burden, relationship stress, fatigue, and reduced quality of life. Dialysis can keep a patient alive, but it does not automatically restore sexual function.

That is why sildenafil has been studied in men receiving hemodialysis.

But the key question is not only whether sildenafil can improve erections. It is also whether dialysis changes the drug’s behavior.

That is the clinical issue behind Nizagara 100 sildenafil hemodialysis clearance study.

## Hemodialysis did not clear sildenafil

A pharmacokinetic study in *Kidney International* evaluated 15 men receiving chronic outpatient maintenance hemodialysis. Each participant received a single 50 mg oral sildenafil dose twice: once 2 hours before hemodialysis and once 2 hours after hemodialysis, with randomized sequence assignment.

The result was specific: hemodialysis did not significantly clear sildenafil or its primary metabolite. Administration after dialysis produced a 17% higher peak concentration and earlier time to peak, but the authors considered these differences not clinically meaningful. Overall absorption and elimination half-life were not affected.

The study also found that sildenafil did not promote intradialytic hypotension. Blood pressure did not collapse simply because sildenafil was given before dialysis.

That is an important finding, but it is easy to misread.

It does not mean sildenafil is risk-free in dialysis patients. It means dialysis should not be assumed to remove the drug if dosing goes wrong.

## The 100 mg problem

Nizagara 100-style products are usually framed around dose strength.

That framing matters because the hemodialysis pharmacokinetic study used 50 mg, not 100 mg. The older controlled efficacy study in hemodialysis patients also used sildenafil 50 mg as needed.

In that randomized placebo-controlled study, improvement in erectile function was observed in 85% of sildenafil patients compared with 9.5% of placebo patients. Sildenafil improved most International Index of Erectile Function domains except sexual desire, and 35% of sildenafil-treated patients reached normal erectile-function scores.

That sounds impressive, but the patient selection was strict. The study excluded men older than 70, men with diabetes, angina, severe anemia, nitrate treatment, recent stroke, recent myocardial infarction, cirrhosis, and penile anatomical abnormalities.

That means the result applies to selected dialysis patients, not every man on hemodialysis.

## Why “dialysis will remove it” is unsafe thinking

Some patients assume that dialysis can “clean out” medicines if there is a problem.

For sildenafil, that assumption is not reliable.

The hemodialysis pharmacokinetic study found that sildenafil was about 96% bound to plasma protein in hemodialysis patients. Highly protein-bound drugs are generally less available for dialysis removal. This helps explain why sildenafil was not significantly cleared by hemodialysis.

That matters clinically. If a patient takes too much sildenafil, combines it with nitrates, uses it with riociguat, stacks it with other PDE5 inhibitors, or adds a strong CYP3A4 inhibitor, dialysis should not be viewed as a simple rescue method.

The safer strategy is preventing the dosing mistake before it happens.

## Kidney disease patients often have overlapping risks

Hemodialysis patients frequently have cardiovascular disease, diabetes, hypertension, anemia, fluid shifts, autonomic dysfunction, polypharmacy, and vascular calcification. Some also use alpha-blockers, antihypertensives, nitrates, antifungals, macrolide antibiotics, HIV medicines, or other drugs that can change sildenafil safety.

That is why the sexual-function question cannot be separated from the dialysis medication list.

A man may be stable enough for sexual activity and sildenafil. Another may have unstable blood pressure, active angina, nitrate therapy, severe anemia, or recent cardiovascular events that make sildenafil unsafe.

The same drug can be reasonable in one dialysis patient and inappropriate in another.

## The practical takeaway

Nizagara 100 should not be judged only by the number on the package.

Sildenafil has evidence of benefit in selected hemodialysis patients with erectile dysfunction. But dialysis does not significantly remove sildenafil, and the best-studied doses in this population were not automatically 100 mg.

For men on hemodialysis, sildenafil use should be clinician-reviewed, especially when cardiovascular disease, nitrate exposure, blood-pressure medication, anemia, diabetes, or recent hospitalization is present.

Dialysis may replace kidney function.

It does not replace dose judgment.

Disclaimer

This article is for informational and educational purposes only. It is not medical advice, diagnosis, or treatment. Sildenafil or any erectile dysfunction medication should be used only under the guidance of a qualified healthcare professional, especially in patients with kidney failure or those receiving dialysis.

References

1. The](https://www.sciencedirect.com/science/article/pii/S0085253815500392]The) Pharmacokinetics and Hemodynamics of Sildenafil Citrate in Male Hemodialysis Patients
2. The](https://pubmed.ncbi.nlm.nih.gov/15200445/]The) Pharmacokinetics and Hemodynamics of Sildenafil Citrate in Male Hemodialysis Patients — PubMed
3. Efficacy](https://pubmed.ncbi.nlm.nih.gov/12397048/]Efficacy) of Oral Sildenafil in Hemodialysis Patients With Erectile Dysfunction
4. Efficacy](https://www.academia.edu/92183096/Efficacy_of_Oral_Sildenafil_in_Hemodialysis_Patients_with_Erectile_Dysfunction]Efficacy) of Oral Sildenafil in Hemodialysis Patients With Erectile Dysfunction — Full Text
5. Sildenafil](https://journals.lww.com/ijon/fulltext/2010/20030/sildenafil_citrate_can_improve_erectile.5.aspx]Sildenafil) Citrate Can Improve Erectile Dysfunction Among Chronic Hemodialysis Patients